期刊文献+

Radiofrequence ablation of liver cancers 被引量:13

Radiofrequence ablation of liver cancers
暂未订购
导出
摘要 Primary and secondary malignant liver cancer are some of most common malignant tumors in the world. Chemotherapy and radiotherapy are not very effective against them. Surgical resection has been considered the only potentially curtive option, but the majority of patients are not candidates for resection because of tumor size, location near major intrahepatic blood vessels and bile ducts, precluding a margin-negative resection, cirrhotic, hepatitis virus infection or multifocial. Radiofrequence ablation (RFA), which is a new evolving effective and minimally invasive technique, can produce coagulative necrosis of malignant tumors. RFA should be used percutaneously, laparascopically, or during the open laparotomy under the guidance of ultrasound, CT scan and MRI. RFA has lots of advantages superior to other local therapies including lower complications, reduced costs and hospital stays, and the possibility of repeated treatment. In general, RFA is a safe, effective treatment for unresectable malignant liver tumors less than 7.0 cm in diameter. We review the principle, mechanism, procedures and experience with RFA for treating malignant liver tumors. Primary and secondary malignant liver cancers are some ofmost common malignant tumors in the world.Chemotherapy and radiotherapy are not very effectiveagainst them. Surgical resection has been considered theonly potentially curtive option, but the majority of patientsare not candidates for resection because of tumor size,location near major intrahepatic blood vessels and bileducts, precluding a margin-negative resection, cirrhotic,hepatitis virus infection or multifocial. Radiofrequenceablation (RFA), which is a new evolving effective andminimally invasive technique, can produce coagulativenecrosis of malignant tumors. RFA should be usedpercutaneously, laparscopically, or during the openlaparotomy under the guidance of ultrasound, CT scan andMRI. RFA has lots of advantages superior to other localtherapies including lower complications, reduced costs andhospital stays, and the possibility of repeated treatment. Ingeneral, RFA is a safe, effective treatment for unresectablemalignant liver tumors less than 7.0 cm in diameter. Wereview the principle, mechanism, procedures andexperience with RFA for treating malignant liver tumors.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第3期393-399,共7页 世界胃肠病学杂志(英文版)
基金 Youth Natural Scientific Foundation of Heilongjiang Province Natural Scientific Foundation of Harbin
  • 相关文献

参考文献3

二级参考文献16

共引文献272

同被引文献121

  • 1Jia Fan,Zhi Quan Wu,Zhao You Tang,Jian Zhou,Shuang Jian Qiu,Zeng Chen Ma,Xin Da Zhou,Sheng Long Ye Liver Cancer Institute, Zhongshan Hospital, Fudan University Medical Center (Former Shanghai University), 136 Yixueyuan Road, Shanghai 200032, China.Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein[J].World Journal of Gastroenterology,2001,7(1):28-32. 被引量:80
  • 2Yong Chuan Deng1,Yong Su Zhen2,Shu Zheng1,Yu Chuan Xue2 1Cancer Institute, Medical School, Zhejiang University, Hangzhou 310009, Zhejiang Province, China2Institute of Medicinal Biotechnology, CAMS & PUMC, Beijing 100050, China.Activity of boanmycin against colorectal cancer[J].World Journal of Gastroenterology,2001,7(1):93-97. 被引量:5
  • 3Christian Rabe,Tillmann Pilz,Christoph Klostermann,Marc Berna,Hans H.Schild,Tilman Sauerbruch,Wolfgang H.Caselmann.Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2001,7(2):208-215. 被引量:61
  • 4Ping Yuan~1 Meng Hong Sun~2 Jin Sheng Zhang~1 Xiong Zeng Zhu~2 Da Ren Shi~2 ~1Department of Pathology,Medical College of Fudan University,~2Department of Pathology,Cancer Hospital/Cancer Institute,Fudan University,Shanghai 200032,ChinaDr.Ping Yuan Studying Province.studying in Medical College of Fudan University,worked in Department of Pathology,Wannan Medical College,having eighteen papers published..APC and K-ras gene mutation in aberrant crypt foci of human colon[J].World Journal of Gastroenterology,2001,7(3):352-356. 被引量:21
  • 5Jun Hui Cui~1 Uwe Krueger~2 Doris Henne-Bruns~2 Bemd Kremer~2 Holger Kalthoff~2 ~1Department of General Surgery,First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,Zhejiang Province,China ~2Department of General Surgery,Christian-Albrechts-University,Kiel,GermanyDr.Jun Hui Cui graduated from Zhejiang Medical University in 1984,earned master degree in 1990,studied in the Surgical Department of Kiel University and worked in the Lab of Molecular Oncology of Kiel University from 1994-1997achieved M.D.from Kiel University.Germany,now associate professor of surgery,specialized in colorectal oncology.Adviser of graduated student for master degree,having 20 publications published in key Chinese or English journals..Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases[J].World Journal of Gastroenterology,2001,7(3):381-386. 被引量:19
  • 6Xiao Wei Li~1 Yan Qing Ding~1 Jun Jie Cai~1 Shao Qing Yang~2 Lian Bing An~3 Dong Fang Qiao~3 ~1Department of Pathology,Nanfang Hospital of the First Military Medical University,Guangzhou 510515,Guangdong Province,China ~2The Northern Hospital of PLA,Shenyang 110015,Liaoning Province,China ~3Department of Electronmicroscopy,First Military Medical University,Guangzhou 510515,Gangdong Province,ChinaDr.Xiao Wei Li graduated from the First Military Medical University with a MM degree in 1999.Physician in Charge of pathology,having 6 papers published..Studies on mechanism of Sialy Lewis-X antigen in liver metastases of human colorectal carcinoma[J].World Journal of Gastroenterology,2001,7(3):425-430. 被引量:19
  • 7Chao Xu Zheng~1 Wen Hua Zhan~1 Ji Zong Zhao~2 Dong Zheng~3 Dong Ping Wang~1 Yu Long He~1 Zhang Qing Zheng~1 ~1Department of General Surgery,~2Laboratory of Surgery,~3Department of Medicine,First Affiliated Hospital,Sun Yat-Sen University of Medical Sciences,Guangzhou 510080,Guangdong Province,ChinaDr.Chao Xu Zheng now working as a surgeon and lecturer in the Department of General Surgery,First Affiliated Hospital,Sun Yat-Sen University of Medical Sciences,who is a Ph.D.student,having 7 papers published..The prognostic value of preoperative serum levels of CEA,CA19-9 and CA72-4 in patients with colorectal cancer[J].World Journal of Gastroenterology,2001,7(3):431-434. 被引量:25
  • 8Li Ping Wang~1 Ke Liang~2 Yu Shen~2 Wei Bo Yin~2 G.Hans~3 Yan Jun Zeng~1 ~1Biomechanics & Medical Information Institute,Beijing Polytechnic University,Beijng 100022,China ~2Department of Gastrointestinal Surgery,Aalborg University,Denmark ~3Cancer Institute (Hospital),Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,ChinaLi Ping Wang graduated from Beijing Polytechnic University in 2000,major in tumor radiotherapy,having 3 papers published..Neutron-induced apoptosis of HR8348 cells in vitro[J].World Journal of Gastroenterology,2001,7(3):435-439. 被引量:5
  • 9Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 10Xing-Guo Li Jin-Dan Song Yun-Qing Wang Key Laboratory of Cell Biology,Ministry of Public Health of China,China Medical University,Shenyang 110001,Liaoning Province,China.Differential expression of a novel colorectal cancer differentiation-related gene in colorectal cancer[J].World Journal of Gastroenterology,2001,7(4):551-554. 被引量:7

引证文献13

二级引证文献263

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部